People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. | — | Pharma | Series B | $31.8M | $591.3M | 2021 |
Simon Dumesnil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Simon Dumesnil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lawrence Steinman | 1 | 4 |
| Stanley M. Gloss | 1 | 1 |
| Emer Dos Reis Leahy | 1 | 1 |
| Tiago Andre Dos Reis Marques | 1 | 1 |
| Yassine Bendiabdallah | 1 | 1 |
| Lawrence Reis Steinman | 1 | 1 |
| Tiago Reis Marques | 1 | 1 |
| Israel Maxx Abramowitz | 1 | 1 |
| Craig Maxx Auringer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.